These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36036339)
1. Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions. Hudzik B; Błachut A; Lesiak M; Kubica J; Wojakowski W; Gąsior M Kardiol Pol; 2022; 80(10):974-989. PubMed ID: 36036339 [TBL] [Abstract][Full Text] [Related]
2. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010]. Silber S Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514 [TBL] [Abstract][Full Text] [Related]
3. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis. Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573 [TBL] [Abstract][Full Text] [Related]
4. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry. Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P; Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465 [TBL] [Abstract][Full Text] [Related]
5. Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis. Rodriguez AE; Rodriguez-Granillo AM; Ascarrunz SD; Peralta-Bazan F; Cho MY Curr Pharm Des; 2018; 24(4):465-477. PubMed ID: 29308737 [TBL] [Abstract][Full Text] [Related]
8. Triple antiplatelet therapy in acute coronary syndromes. Valgimigli M; Minarelli M Drugs; 2011 Sep; 71(13):1703-19. PubMed ID: 21902293 [TBL] [Abstract][Full Text] [Related]
9. Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes. Husted S; Boersma E Am J Ther; 2016; 23(6):e1876-e1889. PubMed ID: 25830867 [TBL] [Abstract][Full Text] [Related]
11. Trends of prescribing adherence of antiplatelet agents in Hong Kong patients with acute coronary syndrome: a 10-year retrospective observational cohort study. Lam AS; Yan BP; Lee VW BMJ Open; 2020 Dec; 10(12):e042229. PubMed ID: 33273050 [TBL] [Abstract][Full Text] [Related]
12. Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'target trial'. Pufulete M; Harris J; Pouwels K; Reeves BC; Lasserson D; Loke YK; Mumford A; Mahadevan K; Johnson TW Open Heart; 2022 Aug; 9(2):. PubMed ID: 35961692 [TBL] [Abstract][Full Text] [Related]
13. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233 [TBL] [Abstract][Full Text] [Related]
14. Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry. De Filippo O; Cortese M; D Ascenzo F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Montefusco A; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Rinaldi M Am J Cardiovasc Drugs; 2019 Aug; 19(4):381-391. PubMed ID: 31030413 [TBL] [Abstract][Full Text] [Related]
15. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention. Abraham NS; Yang EH; Noseworthy PA; Inselman J; Yao X; Herrin J; Sangaralingham LR; Ngufor C; Shah ND Aliment Pharmacol Ther; 2020 Aug; 52(4):646-654. PubMed ID: 32657466 [TBL] [Abstract][Full Text] [Related]
16. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry. Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837 [TBL] [Abstract][Full Text] [Related]
18. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor. Bianco M; D'ascenzo F; Raposeiras Roubin S; Kinnaird T; Peyracchia M; Ariza-Solé A; Cerrato E; Manzano-Fernández S; Gravinese C; Templin C; Destefanis P; Velicki L; Luciano A; Xanthopoulou I; Rinaldi M; Rognoni A; Varbella F; Boccuzzi G; Omedè P; Montabone A; Bernardi A; Taha S; Rossini R; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Giustetto C; Garay A; Quadri G; Queija BC; Srdanovic I; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Lopez-Cuenca Á; Cequier A; Alexopoulos D; Iñiguez-Romo A; Pozzi R; Assi EA; Valgimigli M Int J Cardiol; 2020 Feb; 301():200-206. PubMed ID: 31785951 [TBL] [Abstract][Full Text] [Related]
19. Survey of clinical practice pattern in Germany's certified chest pain units : Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome. Breuckmann F; Settelmeier S; Rassaf T; Post F; Haerer W; Bauersachs J; Mudra H; Voigtländer T; Senges J; Münzel T; Giannitsis E Herz; 2022 Dec; 47(6):543-552. PubMed ID: 34755215 [TBL] [Abstract][Full Text] [Related]